Document reference

2017/2710(DEA)  
Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections  
Basic information  

2017/2710(DEA)

DEA - Delegated acts procedure

Supplementing 2012/0192(COD)

Subject
4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

 

Key players  
  • Committee responsible
    Rapporteur
    Appointed
    ENVI  
    Environment, Public Health and Food Safety
Key events  
23/05/2017
Non-legislative basic document published
23/05/2017
Initial period for examining delegated act 2 month(s)
31/05/2017
Committee referral announced in Parliament
17/07/2017
Delegated act not objected by Council
01/08/2017
Delegated act not objected by Parliament
Technical information  
Procedure reference
2017/2710(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/8/10003
Documentation gateway